Joaquim Vives

Has grant

Associate Medical Lecturer (external)

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Tissue Engineering Tissue Engineering professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joaquim Vives is an Associate Medical Lecturer (external) at Universitat Autònoma de Barcelona, Spain. His research focuses on cell and gene therapy, specifically in the realm of mesenchymal stromal cells and bone tissue engineering. Recent publications include explorations of various preclinical and clinical applications of Wharton’s jelly-derived cells, highlighting their potential in regenerative medicine and advanced therapy medicinal products.

Recent Grants

Grant: Close

Translation of an allogenic tissue engineering product with msc from wharton’s jelly for the treatment of osteonecrosis in paediatric oncology patients.

Open Date: 2020-01-01

Close Date: 2022-12-01

Grant: Close

Translation of an allogenic tissue engineering product with msc from wharton’s jelly for the treatment of osteonecrosis in paediatric oncology patients.

Open Date: 2019-12-01

Close Date: 2022-12-01

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Christian Chabannon

Professor in Cell Biology

Aix-Marseille Université Faculté de Medecine

FRANCE

View details

John De Vos

University of Montpellier

FRANCE

View details

Etienne BAUDOUX

University of Liege

BELGIUM

View details

Fermin Sanchez-Guijo

Full-Professor of Medicine (Catedrático de Medicina)

Universidad de Salamanca

SPAIN

View details

Xavier Navarro

Professor

University of Barcelona

SPAIN

View details

Rosario Sanchez-Pernaute

Ikerbasque Research Professor

Ikerbasque, Basque Foundation for Science

SPAIN

View details

Jurgen Kuball

UMC Utrecht

NETHERLANDS

View details

Joaquim Hernandez

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joaquim Vives

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton’s Jelly Mesenchymal Stromal Cells

Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)

Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft

Identification of critical process parameters for expansion of clinical grade human Wharton's jelly‐derived mesenchymal stromal cells in stirred‐tank bioreactors

Comparability exercise of critical quality attributes of clinical-grade human mesenchymal stromal cells from the Wharton’s jelly: single-use stirred tank bioreactors versus planar culture systems

Preservation of critical quality attributes of mesenchymal stromal cells in 3D bioprinted structures by using natural hydrogel scaffolds

Cell and gene therapy workforce development: the role of the International Society for Cell & Gene Therapy (ISCT) in the creation of a sustainable and skilled workforce in Europe

Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use

A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience

A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe

Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment

Compliance in Non-Clinical Development of Cell-, Gene-, and Tissue-Based Medicines: Good Practice for Better Therapies

Optimisation of processing methods to improve success in the derivation of human multipotent mesenchymal stromal cells from cryopreserved umbilical cord tissue fragments

Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance

The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance

A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones

Collaborators (8)

Christian Chabannon

John De Vos

Etienne BAUDOUX

Fermin Sanchez-Guijo

Xavier Navarro

Rosario Sanchez-Pernaute

Jurgen Kuball

Joaquim Hernandez

Make your next move.